Ingalls & Snyder LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$168K	Hold	10,000	–	–	0.01%	420
2025 Q1	$154K	Buy	+10,000	New	+$154K	0.01%	407
2017 Q3	–	Sell	-8,188	Closed	-$272K	–	366
2017 Q2	$272K	Buy	+8,188	New	+$272K	0.01%	296